Reported on Monday by the Wall Street Journal which cited people who are close to the matter, French drug maker Sanofi SA is closing a deal to take over Bioverativ Inc. for over $11.5 billion. The potential deal values Bioverativ at around $105 a share according to the Journal. It is also 64% premium compared … Continue reading “Sanofi is Closing a Deal to Buy This U.S. Drug Maker”
